Tryptophan hydroxylase-1 regulates immune tolerance and inflammation
Open Access
- 24 September 2012
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 209 (11), 2127-2135
- https://doi.org/10.1084/jem.20120408
Abstract
Tryptophan hydroxylase deficiency in mast cells breaks allograft tolerance, induces tumor remission, and intensifies neuroinflammation.Keywords
This publication has 34 references indexed in Scilit:
- Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenaseProceedings of the National Academy of Sciences of the United States of America, 2012
- Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and CysteineCancer Research, 2010
- Mast cells in tumor growth: Angiogenesis, tissue remodelling and immune-modulationBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2009
- Infectious tolerance via the consumption of essential amino acids and mTOR signalingProceedings of the National Academy of Sciences of the United States of America, 2009
- IL-9 as a mediator of Th17-driven inflammatory diseaseThe Journal of Experimental Medicine, 2009
- The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage CommitmentImmunity, 2009
- Role of a Serotonin Precursor in Development of Gut MicrovilliThe American Journal of Pathology, 2008
- Indoleamine 2,3-dioxygenase and tumor-induced toleranceJCI Insight, 2007
- Hormones in the nucleus. Immunologically demonstrable biogenic amines (serotonin, histamine) in the nucleus of rat peritoneal mast cellsLife Sciences, 2006
- Mast Cell-Deficient W-sash c-kit Mutant KitW-sh/W-sh Mice as a Model for Investigating Mast Cell Biology in VivoThe American Journal of Pathology, 2005